ArticleAging clinical and experimental research2025
Cognitive frailty and cardiometabolic risk in middle-aged and older adults: evidence from the UK and China.
Article in Aging clinical and experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Association between the cardiometabolic index and intrinsic capacity and its domains in older adults: a study based on CHARLS data.BMC geriatrics · 2026Article
- Novel lipid and obesity indices with new-onset stroke among adults aged 50 years and older in England.Scientific reports · 2026Article
- The impact of exercise interventions on cognitive frailty: a scoping review of outcomes and biological mechanisms.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCognitive frailty, a novel construct integrating cognitive and physical deficits, is increasingly recognized in aging research.
aimsThis study aimed to examine the associations between cognitive frailty and cardiometabolic risk in two nationally representative cohorts from China and the United Kingdom.
methodsWe analyzed data from 7,628 participants in the China Health and Retirement Longitudinal Study (CHARLS) and 4,703 participants from the English Longitudinal Study of Ageing (ELSA), all aged ≥ 50 years. Frailty was assessed using the frailty index (FI) in the main analysis. Cox proportional hazards models were applied to estimate hazard ratios (HRs) for incident cardiometabolic diseases (CMDs), cardiovascular diseases (CVDs), and diabetes. Subgroup and interaction analyses were performed to examine effect modification. Restricted cubic spline (RCS) models were used to assess the shape of the association between FI and cardiometabolic risk. Sensitivity analyses employed competing risk models and the physical frailty phenotype (PFP) as an alternative frailty measure.
resultsCognitive frailty was associated with higher risks of CMDs (HR 1.58, 95% CI 1.39-1.79), CVDs (HR 1.64, 95% CI 1.42-1.89), and diabetes (HR 1.39, 95% CI 1.11-1.75). Cognitive impairment alone showed no significant association with these outcomes in the main analysis. Dose-response associations were significant between the FI and CMDs and CVDs among individuals with and without cognitive impairment. Results were consistent across cohorts and robust in sensitivity analyses.
conclusionsCognitive frailty is a consistent predictor of cardiometabolic risk across distinct populations, supporting integrated screening and prevention strategies targeting both cognitive and physical deficits in aging populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.